| Nimesulide 3µM 48hrs |
Buspirone 3µM 48hrs |
| MeSH Term |
p-value |
MeSH Term |
p-value |
| Oxidative Stress |
1.55E-12 |
Cell Hypoxia |
3.44E-26 |
| Gene Expression Regulation, Neoplastic |
6.70E-07 |
Anoxia |
1.30E-14 |
| Pulmonary Disease, Chronic Obstructive |
2.04E-06 |
Lipid Metabolism |
1.40E-13 |
| Liver Neoplasms |
2.37E-06 |
Gene Expression Regulation, Enzymologic |
2.43E-08 |
| Carcinoma, Hepatocellular |
2.48E-06 |
Gene Expression Regulation, Neoplastic |
3.15E-07 |
| Lipid Metabolism |
8.36E-05 |
Glycolysis |
1.17E-06 |
| Emphysema |
1.05E-04 |
Fasting |
3.54E-05 |
| Metabolic Detoxication, Phase II |
3.13E-04 |
Genes, myc |
8.53E-05 |
| Gene Expression Regulation, Enzymologic |
3.24E-04 |
Osmotic Pressure |
1.03E-04 |
| Oxidation-Reduction |
6.61E-04 |
Oxidation-Reduction |
2.08E-04 |
| Organ Size |
9.24E-04 |
Adaptation, Physiological |
4.17E-04 |
The MeSH term enrichment analysis provides the biological context of the evidence supporting the CRE molecular hypotheses. The p-values are computed by Fisher’s
exact test. |
